Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.64 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.58 |
| ▸ | RAD52 | P43351 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | DGKA | P23743 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 2/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2854828 | 1.00 | NAAA (0.64) | NAAADNM1RAD52NPSR1DGKA | |
| SCHEMBL1553143 | 1.00 | NAAA (0.64) | NAAADNM1RAD52NPSR1DGKA | |
| SCHEMBL31136183 | 1.00 | NAAA (0.64) | NAAADNM1RAD52NPSR1DGKA | |
| SCHEMBL6667798 | 1.00 | NAAA (0.64) | NAAADNM1RAD52NPSR1DGKA | |
| SCHEMBL1671755 | 1.00 | NAAA (0.64) | NAAADNM1RAD52NPSR1DGKA | |
| SCHEMBL465967 | 1.00 | NAAA (0.64) | NAAADNM1RAD52NPSR1DGKA | |
| SCHEMBL1672723 | 1.00 | NAAA (0.64) | NAAADNM1RAD52NPSR1DGKA | |
| SCHEMBL8374691 | 1.00 | NAAA (0.64) | NAAADNM1RAD52NPSR1DGKA | |
| Hydrochloric Acid SCHEMBL10576792 | 0.98 | NAAA (0.62) | NAAADNM1RAD52NPSR1DGKA | |
| Hydrochloric Acid SCHEMBL5269037 | 0.98 | NAAA (0.62) | NAAADNM1RAD52NPSR1DGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12103115-B2 | Brazing material, brazing member, heat exchanger, and producing method of brazing member | HARIMA CHEMICALS, INCORPORATED (JP) | 2024-10-01 | — | — | US | disclosed |
| US-20130251788-A1 | Method of Inducing a Phase Transition of a Bilayer Membrane Vesicle | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-09-26 | — | — | US | disclosed |
| US-8449979-B2 | Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-05-28 | — | — | US | disclosed |
| US-8449979-B2 | Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-05-28 | — | — | US | disclosed |
| EP-1714962-B1 | DEHYDRATING CONDENSATION AGENT HAVING PROPERTY OF ACCUMULATING AT INTERFACE WITH WATER | JAPAN SCIENCE & TECH AGENCY (JP) | 2011-04-27 | — | — | EP | disclosed |
| EP-1714962-B1 | DEHYDRATING CONDENSATION AGENT HAVING PROPERTY OF ACCUMULATING AT INTERFACE WITH WATER | JAPAN SCIENCE & TECH AGENCY (JP) | 2011-04-27 | — | — | EP | disclosed |
| US-7857861-B2 | Hydrophilizing agent and hydrophilized fiber treated therewith | MATSUMOTO YUSHI-SEIYAKU CO., LTD. (JP) | 2010-12-28 | — | — | US | disclosed |
| CN-101111306-B | Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof | JAPAN SCIENCE & TECH AGENCY | 2010-09-29 | — | — | CN | disclosed |
| US-20090023003-A1 | Molecular Aggregate Capable of Undergoing Phase Transition by Dehydrating Condensation and Method of Phase Transition Thereof | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20090023003-A1 | Molecular Aggregate Capable of Undergoing Phase Transition by Dehydrating Condensation and Method of Phase Transition Thereof | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-01-22 | — | — | US | disclosed |
| CN-1306442-A | Improement in or relating to contrast agents | NYCOMED INAGING AS (NO) | 2001-08-01 | — | — | CN | disclosed |
| EP-1073473-A1 | IMPROVEMENTS IN OR RELATING TO CONTRAST AGENTS | Marsden, John Christopher (GB) | 2001-02-07 | — | — | EP | disclosed |
| WO-1999053963-A1 | IMPROVEMENTS IN OR RELATING TO CONTRAST AGENTS | MARSDEN, JOHN, CHRISTOPHER (GB) | 1999-10-28 | — | — | WO | disclosed |
| CN-1041102-C | Emulsion polymer blend | ROHM & HAAS (US) | 1998-12-09 | — | — | CN | disclosed |
| US-5824708-A | PROPYLENEDIAMINES AND PEPTIDES AS VIRICIDES | HENKEL - ECOLAB GmbH & CO. OHG (DE) | 1998-10-20 | — | — | US | disclosed |
| US-5646105-A | Cleaning disinfectant | HENKEL ECOLAB GMBH & CO. (DE) | 1997-07-08 | — | — | US | disclosed |
| US-5403505-A | An antiseptic concentrate solution comprising a polyamides or polyamideether copolymers, a quaternary ammonium, a phenol, a biguanide and a quaternary phosphonium compounds; stability, water solubility; microbiocides | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1995-04-04 | — | — | US | disclosed |
| CN-1095084-A | Emulsion polymer blend | ROHM & HAAS (US) | 1994-11-16 | — | — | CN | disclosed |
| EP-0570383-A1 | PROCESS FOR PREPARING SOLID BETAINES. | ETHYL CORP (US) | 1993-11-24 | — | — | EP | disclosed |
| WO-1992013825-A1 | PROCESS FOR PREPARING SOLID BETAINES | ETHYL CORPORATION (US) | 1992-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130251788-A1 | Method of Inducing a Phase Transition of a Bilayer Membrane Vesicle | VAPB, VAPA, NSF | NAAA 698/4885DNM1 325/4885RAD52 2141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.